If the patient shows cortical infarction with severe vasculitis and no specific immunologic and anatomical risks, the possibility of ABMR by non-HLA anti-AT1R antibody should be considered, and if suspected, aggressive treatment should be performed as soon as possible. The gene discussed is AGTR1; the disease is vasculitis.